The Role of Systemic Inflammation in Acquired Nasolacrimal Duct Obstruction

Overview

Journal Beyoglu Eye J

Publisher Kare Publishing

Specialty Ophthalmology

Date 2023 Dec 13

PMID 38089075

Authors

Yasar Dag

Yakup Acet

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aims to investigate the influence of systemic inflammation on adult patients with acquired nasolacrimal duct obstruction (ANLDO).

Methods: Peripheral venous blood analysis was performed on adult patients who underwent dacryocystorhinostomy for ANLDO between June 2020 and December 2022, during their remission period just before the surgery. Platelet, Neutrophil, Lymphocyte, Monocyte, White Blood Cell (WBC) count, Platelet/Lymphocyte ratio (PLR), Neutrophil/Lymphocyte ratio (NLR), Monocyte/Lymphocyte ratio (MLR), and systemic inflammatory index (SII) (calculated as platelet × (neutrophil/lymphocyte)) were compared with a volunteer control group.

Results: The study included 54 adult patients with ANLDO and 54 individuals in the control group. The mean age was 42.5±14.4 years in the ANLDO group and 37.8±12.3 years in the volunteer control group. There was no significant difference in age between the groups (p=0.064). Platelet value (295.9±70.9→254.7±43.9), PLR value (143.8±77.7→119.0±36.1), and SII value (534.7±192.0→442.6±212.2) in the ANLDO group were significantly higher compared to the Control group (p=0.000, p=0.023, p=0.020, respectively). Neutrophil, lymphocyte, monocyte, NLR, MLR, and WBC values did not exhibit significant differences between the case and control groups (p=0.299, p=0.469, p=0.125, p=0.419, p=0.143, and p=0.465, respectively).

Conclusion: The study revealed elevated systemic platelet counts in ANLDO patients, resulting in higher PLR and SII values. The authors suggest that a histopathological examination to assess the local impact of platelets or other inflammatory processes in nasolacrimal duct obstruction could offer valuable insights into the etiopathology of ANLDO.

References

Ali M, Paulsen F . Etiopathogenesis of Primary Acquired Nasolacrimal Duct Obstruction: What We Know and What We Need to Know. Ophthalmic Plast Reconstr Surg. 2019; 35(5):426-433. DOI: 10.1097/IOP.0000000000001310. View

Ali M, Paulsen F . Prolactin and Prolactin-inducible protein (PIP) in the pathogenesis of primary acquired nasolacrimal duct obstruction (PANDO). Med Hypotheses. 2019; 125:137-138. DOI: 10.1016/j.mehy.2019.02.051. View

Qin G, He F, Zhang H, Pazo E, Dai G, Yao Q . Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) are more prominent in retinal artery occlusion (RAO) compared to retinal vein occlusion (RVO). PLoS One. 2022; 17(2):e0263587. PMC: 8812939. DOI: 10.1371/journal.pone.0263587. View

Elbeyli A, Kurtul B . Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio levels are associated with keratoconus. Indian J Ophthalmol. 2021; 69(7):1725-1729. PMC: 8374788. DOI: 10.4103/ijo.IJO_3011_20. View

Mills D, Meyer D . Acquired nasolacrimal duct obstruction. Otolaryngol Clin North Am. 2006; 39(5):979-99, vii. DOI: 10.1016/j.otc.2006.07.002. View

Aksu K, Donmez A, Keser G . Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des. 2012; 18(11):1478-93. DOI: 10.2174/138161212799504731. View

Lee S, Chung S, Lew H . Evaluation of Tear Film Lipid Layer Thickness Measurements Obtained Using an Ocular Surface Interferometer in Nasolacrimal Duct Obstruction Patients. Korean J Ophthalmol. 2018; 32(6):445-450. PMC: 6288021. DOI: 10.3341/kjo.2018.0012. View

Acet Y, Sarikaya S . Another Etiological Factor of Meibomian Gland Loss in Patients with Polycystic Ovary Syndrome: Inflammation. J Ocul Pharmacol Ther. 2022; 38(9):626-634. DOI: 10.1089/jop.2022.0097. View

Makselis A, Petroska D, Kadziauskiene A, Jaruseviciene R, Ruzgys A, Cimbalas A . Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases. BMC Ophthalmol. 2022; 22(1):12. PMC: 8734260. DOI: 10.1186/s12886-021-02185-x. View

10.

Tang B, Li S, Han J, Cao W, Sun X . Associations between Blood Cell Profiles and Primary Open-Angle Glaucoma: A Retrospective Case-Control Study. Ophthalmic Res. 2020; 63(4):413-422. DOI: 10.1159/000504450. View

11.

Ozgonul C, Sertoglu E, Mumcuoglu T, Kucukevcilioglu M . Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Novel Biomarkers of Primary Open-Angle Glaucoma. J Glaucoma. 2016; 25(10):e815-e820. DOI: 10.1097/IJG.0000000000000392. View

12.

Kashkouli M, Sadeghipour A, Kaghazkanani R, Bayat A, Pakdel F, Aghai G . Pathogenesis of primary acquired nasolacrimal duct obstruction. Orbit. 2010; 29(1):11-5. DOI: 10.3109/01676830903207828. View

13.

Avdagic E, Phelps P . Nasolacrimal duct obstruction as an important cause of epiphora. Dis Mon. 2020; 66(10):101043. DOI: 10.1016/j.disamonth.2020.101043. View

14.

Akboga M, Canpolat U, Yayla C, Ozcan F, Ozeke O, Topaloglu S . Association of Platelet to Lymphocyte Ratio With Inflammation and Severity of Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease. Angiology. 2015; 67(1):89-95. DOI: 10.1177/0003319715583186. View

15.

Lee I, Chen W, Chen Q, Cole H, Bischoff L, Jessop A . Factors Associated With Radioactive Iodine Therapy-Acquired Nasolacrimal Duct Obstruction. Endocr Pract. 2022; 28(12):1210-1215. DOI: 10.1016/j.eprac.2022.08.006. View

16.

Sarkar S, Kannan S, Khanna P, Singh A . Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis. J Med Virol. 2021; 94(1):211-221. PMC: 8661888. DOI: 10.1002/jmv.27297. View

17.

Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D . Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol. 2021; 99:107995. PMC: 8295197. DOI: 10.1016/j.intimp.2021.107995. View

18.

Schittkowski M, Stropahl G, Timm A, Guthoff R . [Nasolacrimal duct obstruction caused by a cylindroma. Report of an atypical tumor manifestation and review of the literature]. Klin Monbl Augenheilkd. 2002; 219(8):602-8. DOI: 10.1055/s-2002-34424. View

19.

Ali M, Patnaik S, Kelkar N, Ali M, Kaur I . Alteration of Tear Cytokine Expressions in Primary Acquired Nasolacrimal Duct Obstruction - Potential Insights into the Etiopathogenesis. Curr Eye Res. 2019; 45(4):435-439. DOI: 10.1080/02713683.2019.1665186. View

20.

Nassif S, Ruiz D, Callahan A, Rebeiz E . Nasolacrimal Duct Obstruction: An Unusual Presentation of Sarcoidosis. Ear Nose Throat J. 2020; 101(4):NP143-NP145. DOI: 10.1177/0145561320950494. View